Pallas Health vs Vaylen: Cost, formats, and clinician review
Quick verdict: Pallas Health vs Vaylen splits on pricing strategy and product flow. Pallas gives clinician-selected access to brand-name pens or US-compounded semaglutide with a $139 first-month entry and provider care bundled. Vaylen emphasizes the lowest headline monthly rate for prepaid plans, with semaglutide from $83.25/mo on a 12-month program and a pay-first model that includes a full refund if a clinician declines.
Start Pallas intake and clinician review
How Pallas Health vs Vaylen differ at a glance
Compare the most distinctive differences directly: pricing and billing cadence, medication formats and brand access, when payment happens and refund terms, and clinician workflow and state availability. Both offer compounded GLP-1 options and both include free discreet shipping, but the experience and payment terms differ.
1) Pricing model and headline rates
Pallas publishes compounded semaglutide at $139 for the first month, then $597 every 12 weeks which averages $199 per month, and compounded tirzepatide at $179 first month then $897 every 12 weeks ($299/mo average). Pallas also lists cash-pay brand-name prices for Wegovy, Ozempic, Zepbound and Mounjaro as separate monthly cash-pay rates.
Vaylen advertises lower annualized headline rates when prepaid: semaglutide from $83.25/mo on a 12-month plan (billed upfront), oral semaglutide at $99/mo on the 12-month plan, and tirzepatide at $149/mo on the 12-month plan. The same Vaylen options are substantially higher if paid month to month, for example $224/mo for injectable semaglutide.
See Vaylen prepaid pricing and clinician terms
2) When you pay and refund policy
Pallas follows a clinician-review-first workflow: a US-licensed clinician reviews your health history and personalizes the plan, and pricing varies by whether you choose a brand pen or a compounded plan. Pallas states plan prices include provider care and have no membership fee.
Vaylen requires prepayment for the 12-month plan before a clinician review, then promises a full refund for that billing cycle if a clinician declines to prescribe. That pay-first model is explicit and meant to secure the prepaid rate.
3) Medication formats and brand access
Pallas offers both FDA-approved brand-name pens such as Wegovy, Ozempic, Zepbound and Mounjaro and US-compounded semaglutide or tirzepatide when a brand medication is not the right fit. Pallas notes compounded medications are prepared by US-licensed compounding pharmacies and are not FDA-approved finished products.
Vaylen sells compounded semaglutide injections, oral semaglutide tablets, and compounded tirzepatide. Vaylen emphasizes a needle-free oral tablet option at $99/mo on the prepaid plan and states all medications offered in its model are compounded and not FDA-approved finished products.
Choose Pallas for brand or compounded choice
4) Clinician workflow, approvals and availability
Pallas is 100% online and asynchronous in most states, noting that 43 of 50 states need no video visit but a video visit is required in seven states plus Washington, D.C. Eligibility is determined by a US-licensed clinician and Pallas says care-team hours are weekdays 9 AM to 5 PM ET. Pallas is LegitScript Healthcare Merchant Certified and provides clinician review inside the plan price.
Vaylen says clinician review occurs within 24 hours after prepayment and is available in all 50 states, with licensed U.S. clinicians via OpenLoop Health and HIPAA protection. Vaylen highlights a $0 consultation fee bundled into plan prices and 1 to 3 business day free discreet shipping.
Comparison table: Pallas Health vs Vaylen
| Criteria | Pallas Health | Vaylen |
| Starting price (compounded semaglutide) | $139 first month, then $597/12 weeks ($199/mo avg) | $83.25/mo on 12-month plan or $224/mo month to month |
| Medication formats | Brand-name pens and US-compounded injections | Compounded injections, oral tablets, and tirzepatide |
| When clinician reviews you | Clinician review before plan; eligibility determined by clinician | Prepay first, clinician reviews within 24 hours; full refund if declined |
| State availability / visit type | 100% online; asynchronous in most states; video required in 7 states + D.C. | Licensed in all 50 states; telehealth by live video or asynchronous review |
| Compounded medication notes | Compounded in USA; not FDA-approved finished products | Compounded medications; not FDA-approved finished products |
5) Shipping, refunds and support
Pallas offers free expedited discreet shipping and lets you manage refills and plan changes through a self-serve portal; refunds are offered if a clinician decides treatment is not right for you. Vaylen advertises free discreet shipping in 1 to 3 business days, cancel anytime, and a published full refund if the clinician declines to prescribe your prepaid cycle.
Begin Pallas intake and view brand options
Start Vaylen prepaid plan and clinician review
Which to choose: final guidance
Choose Pallas Health if you want a clinician to decide between a brand-name pen and a per-patient compounded preparation, prefer clinician review before paying, and value an all-in plan price that includes provider care and check-ins with no membership fee. Choose Vaylen if you prioritize the lowest headline monthly rate via a prepaid 12-month plan, want an oral semaglutide tablet option, and accept prepaying with a published full refund if a clinician declines.
Both providers state that compounded medications are not FDA-approved finished products and that eligibility and prescriptions are subject to clinician review. Confirm current pricing and terms directly with each provider before you order.